Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
QuidelOrtho Corporation unites the strengths of Quidel Corporation and Ortho Clinical Diagnostics, forming a global leader in the development and manufacturing of innovative in vitro diagnostic solutions. The company provides a broad range of products that aid in the diagnosis and monitoring of various diseases and health conditions, from infectious diseases like influenza and COVID-19 to cardiometabolic, autoimmune, and women's health conditions, as well as solutions for blood typing and screening. QuidelOrtho is committed to improving patient outcomes and healthcare efficiency worldwide through reliable and accessible diagnostic testing.
Serves as the central hub for corporate governance, strategic planning, research and development leadership, and global operational oversight for QuidelOrtho.
State-of-the-art R&D labs and corporate offices designed to foster collaboration and innovation. Facilities are modern and aligned with biotech industry standards.
Emphasizes innovation, collaboration, customer focus, and a commitment to quality in delivering diagnostic solutions. Employees are driven by the impact of their work on global health.
The San Diego location leverages the region's rich talent pool in life sciences and its ecosystem of research institutions and biotech companies, fostering innovation and strategic partnerships.
QuidelOrtho supports global healthcare needs through a worldwide network of manufacturing sites, R&D centers, commercial offices, and distribution partners. The company's operations span North America, Europe, Asia-Pacific, Latin America, and other key regions, ensuring the development, production, and delivery of diagnostic solutions to laboratories, hospitals, and point-of-care settings across more than 130 countries and territories. Functions supported globally include sales and marketing, customer service and technical support, supply chain and logistics, regulatory affairs, and clinical research.
9975 Summers Ridge Road
San Diego
California
USA
Address: 1001 US-202, Raritan, NJ 08869, USA
Key hub for Americas operations, R&D for specific diagnostic platforms, and manufacturing. Former headquarters of Ortho Clinical Diagnostics.
Address: Ortho Clinical Diagnostics, Pencoed Technology Park, Pencoed, Bridgend CF35 5PZ, United Kingdom
Primary manufacturing and distribution center for Europe, Middle East, and Africa (EMEA), supporting a wide range of diagnostic products.
Address: 3420 West State Street, Athens, OH 45701, USA
Supports high-volume manufacturing of diagnostic tests for the North American market and global distribution.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, QuidelOrtho' leadership includes:
QuidelOrtho has been backed by several prominent investors over the years, including:
QuidelOrtho has actively shaped its executive team over the past 12 months, with key appointments in operations, legal, commercial operations, and an upcoming transition in finance, underscoring its commitment to strategic leadership and operational excellence following its merger.
Discover the tools QuidelOrtho uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
QuidelOrtho commonly uses the email format first.last@quidelortho.com. Variations might exist, but this is a prevalent structure for corporate communications.
first.last@quidelortho.com
Format
jane.doe@quidelortho.com
Example
85%
Success rate
QuidelOrtho Press Release • June 3, 2024
QuidelOrtho Corporation announced that Joseph Busky, Chief Financial Officer, will retire from the Company at the end of July 2024. Bryan L. Giraudo has been appointed to succeed Mr. Busky as Chief Financial Officer, effective July 29, 2024....more
QuidelOrtho Press Release • May 7, 2024
QuidelOrtho Corporation reported its financial results for the first quarter ended March 31, 2024, detailing revenue, earnings, and updates on its product segments and outlook....more
QuidelOrtho Press Release • April 23, 2024
QuidelOrtho highlighted its advanced diagnostic solutions, including new assays and instrument platforms, at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2024, emphasizing its commitment to addressing evolving healthcare challenges....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including QuidelOrtho, are just a search away.